Objective: To investigate and compare glucose and lipid metabolism biomarkers in non-diabetic peritoneal dialysis and hemodialysis patients.
Methods: The study followed a prospective and cross-sectional design.
Participants: Participants included all prevalent end-stage renal disease patients under renal replacement therapy treated in a university-based clinic.